Scholar Rock's Apitegromab Maintains Lean Mass In Phase 2 EMBRAZE Trial With Tirzepatide-Induced Weight Loss
Scholar Rock Holding Corporation (NASDAQ:SRRK) is among the 11 Best GLP-1 and Weight Loss Stocks to Invest in.
Scholar Rock Holding Corp (SRRK)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Siren L.L.C. Raymond Debbane | 9,250,005 | $327,635,177 | 16.95% | |
| 2. | Samsara BioCapital Srini Akkaraju And Michael Dybbs | 5,612,896 | $198,808,776 | 40.66% | |
| 3. | Redmile Group Jeremy Green | 3,929,039 | $139,166,561 | -11% | 14.81% |
| 4. | Hood River Capital Management David Swank | 1,974,964 | $69,953,225 | +2% | 0.98% |
| 5. | Marshall Wace LLP Paul Marshall And Ian Wace | 1,640,437 | $58,104,278 | +1% | 0.07% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $6.85 | 2,189,781 | $14,999,999.85 | 6,788,609 | 2023-10-16 | Filing | |
| $6.85 | 2,189,781 | $14,999,999.85 | 6,788,609 | 2023-10-16 | Filing | |
| $8.55 | 10,150 | $86,735.81 | 11,259,438 | 2023-10-12 | Filing | |
| $6.85 | 2,189,781 | $14,999,999.85 | 11,249,288 | 2023-10-12 | Filing | |
| $6.43 | 31,557 | $202,845.24 | 9,059,507 | 2023-04-28 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $40.02 | 11,136 | $445,688.33 | 0 | 2025-07-16 | Filing | |
| $34.44 | 24,066 | $828,898.02 | 115,495 | 2025-07-08 | Filing | |
| $33.21 | 11,136 | $369,817.65 | 11,136 | 2025-06-23 | Filing | |
| $32.74 | 2,766 | $90,547.22 | 24,070 | 2025-06-23 | Filing | |
| $32.16 | 17,550 | $564,357.11 | 26,836 | 2025-06-23 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 13,834,875 | $490,031,273 | 0.03% | |
| 2. | 6,695,880 | $237,168,069 | 0% | |
| 3. | 4,861,594 | $172,197,659 | 0% | |
| 4. | 3,074,296 | $108,891,564 | 0% | |
| 5. | 2,947,295 | $104,393,189 | 2.3% |
News See All
11 Best GLP-1 and Weight Loss Stocks to Invest in
GLP-1 medicines are a type of prescription that mimics a natural hormone that regulates blood sugar and appetite.
Scholar Rock Holding Corporation (NASDAQ:SRRK) Q2 2025 Earnings Call Transcript
Scholar Rock Holding Corporation (NASDAQ:SRRK) Q2 2025 Earnings Call Transcript August 6, 2025Scholar Rock Holding Corporation misses on earnings expectations.
Scholar Rock (SRRK) Jumps 16.6% After Successful Weight Loss Drug Trial
In a statement, Scholar Rock Holding Corporation (NASDAQ:SRRK) said the trial, which aims to assess its drug candidate apitegromab’s combination with tirzepatide, was generally well tolerated, leading...
Scholar Rock Holding Corporation (NASDAQ:SRRK) Q1 2025 Earnings Call Transcript
Scholar Rock Holding Corporation (NASDAQ:SRRK) Q1 2025 Earnings Call Transcript May 14, 2025Scholar Rock Holding Corporation misses on earnings expectations.
Scholar Rock Holding Corporation (NASDAQ:SRRK) Q4 2024 Earnings Call Transcript
Scholar Rock Holding Corporation (NASDAQ:SRRK) Q4 2024 Earnings Call Transcript February 27, 2025Scholar Rock Holding Corporation misses on earnings expectations.
10 Oversold Biotech Stocks to Buy Now
Biotechnology stocks are among the most volatile in the market, primarily due to the high risks associated with their performance.
Why These 24 Stocks Are Skyrocketing
One of the strongest stock market anomalies is the momentum effect, which is the tendency of recent past winners to outperform the recent past losers.
10 Best Small-Cap Biotech Stocks with Massive Potential According to Hedge Funds
The biotechnology sector is expanding quickly due to rising demand for novel therapies, technological advances, and government assistance.
Scholar Rock Holding Corporation (NASDAQ:SRRK) Q3 2024 Earnings Call Transcript
Operator: Good morning and welcome to Scholar Rock's Third Quarter 2024 Financial Results and Business Update Call. All participants will be in listen-only mode.
Billionaire Hedge Funds
